Kaiser Permanente and Johnson & Johnson’s corporate venturing units have helped Astute Medical, a biomarker-based medical diagnostics firm, raise $40.4m. Kaiser Permanente and Johnson & Johnson Development Corporation were joined in the series C by venture firms MPM Capital, De Novo Ventures, Delphi Ventures and Domain Associates. Last year Astute Medical, a US-based provider of…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
